Fri.Dec 06, 2024

article thumbnail

With green light from European Commission, Novo Holdings' proposed $16.5B Catalent buyout nears close

Fierce Pharma

202
202
article thumbnail

Stronger Cybersecurity in Healthcare Starts with Smart Policy

MedCity News

Leaders across healthcare, technology, and policy circles agree that cybersecurity isn’t just a technical necessity it’s foundational to patient safety The post Stronger Cybersecurity in Healthcare Starts with Smart Policy appeared first on MedCity News.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

CDMO Resilience plots 105 layoffs at Florida plant it acquired in 2021

Fierce Pharma

190
190
article thumbnail

Why the CMO of an Ascension Regional Hospital Likes Wellsheet

MedCity News

Dr. Maria Pulido, chief medical officer, of Ascension St. Vincents, explains why he believes tools like Wellsheet makes the hospital care team’s job so much easier. The post Why the CMO of an Ascension Regional Hospital Likes Wellsheet appeared first on MedCity News.

Medical 105
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Teva, Takeda sell generics joint venture in Japan to focus on innovative drugs

Fierce Pharma

168
168
article thumbnail

Trump’s tariffs could put more pressure on the U.S. to produce generic drugs. Are we ready?

PharmaVoice

93

More Trending

article thumbnail

Atlas closes $450m biotech fund, and other financing news

pharmaphorum

75
article thumbnail

FDA Releases Guidance on Accelerated Approvals

PharmaTech

The draft guidance provides information on the agencys accelerated approval process and criteria for approval.

FDA 69
article thumbnail

Eli Lilly to invest $3bn in Wisconsin facility expansion

Pharmaceutical Technology

Eli has announced a $3bn investment to expand its newly acquired manufacturing facility in Kenosha County, Wisconsin, in the US.

article thumbnail

Hinge Health, Amazon Health Services Team Up to Broaden Access to MSK Care

MedCity News

Hinge Health is the first musculoskeletal care provider to be added to Amazons Health Condition Programs. The post Hinge Health, Amazon Health Services Team Up to Broaden Access to MSK Care appeared first on MedCity News.

67
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Insulin pump firm Insulet wins $452m in trade secrets clash

pharmaphorum

65
article thumbnail

FDA shares new draft guidance for accelerated approval

Pharmaceutical Technology

The new FDA guidance outlines how surrogate or intermediate clinical endpoints can support accelerated approval.

FDA 64
article thumbnail

Drug Digest: Focusing on Solid Dosage Trends and Demand

PharmaTech

In this exclusive Drug Digest video interview an industry expert discusses key trends impacting solid dosage drug development and manufacturing.

article thumbnail

A single mutation could make H5N1 flu a human threat

pharmaphorum

64
article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

Nature study finds obesity costs US industry $347bn a year

Pharmaceutical Technology

A study published in Nature estimates the economic burden associated with obesity on major US industries to be in excess of $347bn in 2023.

59
article thumbnail

Lilly invests another $3bn in its manufacturing network

pharmaphorum

article thumbnail

Cell and gene therapy companies must demonstrate strong value proposition for investment          

Pharmaceutical Technology

Investment for companies developing cell and gene therapies (CGTs) was discussed during the GenScript Biotech Global Forum London 2024 conference held on 20 November 2024.

59
article thumbnail

GSK builds neuro, cancer pipeline with trio of deals

pharmaphorum

61
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Centenarians – unlocking the secrets of living to 100

Pharmaceutical Technology

Centenarians present a unique opportunity for researchers to explore longevity, they demonstrate impressive resilience to illness and injury.

59
article thumbnail

ASH 2024: Bispecific Antibodies Face Key Challenges for Implementation in Community Cancer Centers

Pharmacy Times

Donald Moore discusses some of the obstacles that bispecific antibodies have faced in community cancer centers, including misconceptions coupled with a prevalent toxicity profile.

55
article thumbnail

FDA ARMAT status for Affimed and Artiva’s lymphoma combo therapy

Pharmaceutical Technology

The US FDA has granted RMAT designation to Affimed and Artiva Biotherapeutics combination therapy for lymphoma.

FDA 59
article thumbnail

USDA Announces Federal Order to Test Raw Milk Samples for H5N1 Bird Flu

Pharmacy Times

The US Department of Agricultures (USDA) guidance will help expedite H5N1 bird flu surveillance within the nations milk supply and dairy herds.

52
article thumbnail

Increase Revenue With Better, Faster Sales Onboarding

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

article thumbnail

Muna-GSK alliance to fast-track Alzheimer’s disease treatments

Pharmaceutical Technology

Muna has entered a research alliance with GSK to expedite Alzheimer's disease treatments by discovering and validating new drug targets.

59
article thumbnail

From Challenges to Solutions: Breaking Barriers to Revolutionize Patient Services

Pharmaceutical Commerce

A guide to overcoming the top obstacles facing patient services programs today.

article thumbnail

New study finds obesity costs US industry $347bn a year

Pharmaceutical Technology

A study published in Nature estimates the economic burden associated with obesity on major US industries to be in excess of $347bn in 2023.

52
article thumbnail

National Comprehensive Cancer Network Adds Jazz’s Ziihera as a Category 2A Treatment Option for Biliary Tract Cancers

PharmExec

Ziiheras addition as a category 2A treatment follows the FDAs accelerated approval of the drug for adults with previously treated, unresectable, or metastatic HER2-positive biliary tract cancer.

article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Amgen, Lilly Unveil Major Expansion Projects

Pharmaceutical Commerce

The companies will be financially committing $1 and $3 billion into their respective manufacturing facilities.

article thumbnail

Lilly and Amgen Each Announce Major Expansions of US Manufacturing Sites

PharmaTech

Lilly is investing $3 billion to expand its recently acquired manufacturing facility in Wisconsin, while Amgen is investing $1 billion to expand its facility in North Carolina.

article thumbnail

Navigating the Landscape of Global AI Governance

Pharmaceutical Commerce

The importance of embracing universal values and business models that prioritize humanity.

article thumbnail

The Launch of SPIMA Therapeutics

PharmExec

Mohamed Haitham Ayad, CEO, co-founder, SPIMA Therapeutics, discusses the companys launch and how multiple institutions have supported its pipeline.

52
article thumbnail

Using Generative AI in Sales: Pros, Cons, and Considerations According to Sellers

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A